Summary
Johnson & Johnson (JNJ) filed an 8-K on April 29, 2024, detailing key governance and shareholder meeting outcomes from their 2024 Annual Meeting held on April 25, 2024. The most significant corporate action was the adoption of amended and restated by-laws, which introduce updated procedures for shareholder actions, including calling special meetings and submitting director nominations or proposals. These changes aim to align with current regulatory standards, such as universal proxy rules, and clarify existing corporate governance practices. Furthermore, the filing provides the final voting results from the Annual Meeting. Shareholders overwhelmingly elected all 13 director nominees, approved executive compensation on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2024. Notably, a shareholder proposal requesting a report on gender-based compensation gaps and associated risks was not approved.
Key Highlights
- 1Johnson & Johnson adopted Amended and Restated By-Laws effective April 25, 2024, updating procedural and informational requirements for shareholder actions.
- 2Key by-law updates include enhanced requirements for shareholders to call special meetings and submit director nominations/proposals, incorporating "universal proxy" rules.
- 3All 13 director nominees presented at the 2024 Annual Meeting of Shareholders were elected by shareholders.
- 4Shareholders approved the company's executive compensation philosophy, policies, and procedures on an advisory basis (Say on Pay).
- 5The appointment of PricewaterhouseCoopers LLP as JNJ's independent registered public accounting firm for fiscal year 2024 was ratified.
- 6A shareholder proposal concerning gender-based compensation gaps and associated risks did not receive majority approval.